Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,179 | 15,797 | 74,516 | 54,420 | 42,104 |
| Marketable Securities | 82,508 | 82,143 | 56,128 | 87,510 | 100,196 |
| TOTAL | $136,117 | $99,026 | $131,476 | $143,221 | $142,774 |
| Non-Current Assets | |||||
| PPE Net | 614 | 645 | 671 | 698 | 718 |
| Investments And Advances | 82,905 | 59,142 | 13,797 | 10,913 | 21,073 |
| Other Non-Current Assets | 857 | 2,871 | 1,595 | 446 | 516 |
| TOTAL | $84,376 | $62,658 | $16,063 | $12,057 | $22,307 |
| Total Assets | $220,493 | $161,684 | $147,539 | $155,278 | $165,081 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,862 | 2,193 | 5,311 | 5,469 | 5,030 |
| TOTAL | $6,119 | $3,693 | $5,492 | $5,685 | $5,273 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 986 | 1,236 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 633 | 712 | 153 | 256 | 309 |
| TOTAL | $12,044 | $4,408 | $2,153 | $4,246 | $4,286 |
| Total Liabilities | $18,163 | $8,101 | $7,645 | $9,931 | $9,559 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,802 | 41,004 | 40,850 | 40,850 | 40,312 |
| Common Shares | 490 | 491 | 491 | 480 | 484 |
| Retained earnings | -122,575 | -170,970 | -184,258 | -176,616 | -166,427 |
| Other shareholders' equity | -952 | -946 | -918 | -918 | -919 |
| TOTAL | $202,330 | $153,583 | $139,894 | $145,347 | $155,522 |
| Total Liabilities And Equity | $220,493 | $161,684 | $147,539 | $155,278 | $165,081 |